Combined radio-immunotherapy: An opportunity to increase the therapeutic ratio of oligometastasis-directed radiotherapy
-
Published:2022-05
Issue:
Volume:27
Page:100782
-
ISSN:1476-5586
-
Container-title:Neoplasia
-
language:en
-
Short-container-title:Neoplasia
Author:
Turchan William TylerORCID,
Pitroda Sean P.,
Weichselbaum Ralph R.
Reference56 articles.
1. A perspective on cancer cell metastasis;Chaffer;Science,2011
2. Advances in radiotherapy and implications for the next century: a historical perspective;Connell;Cancer Res,2009
3. Consolidative radiotherapy for limited metastatic non-small-cell lung cancer: a phase 2 randomized clinical trial;Iyengar;JAMA Oncol,2018
4. Local consolidative therapy versus maintenance therapy or observation for patients with oligometastatic non-small-cell lung cancer without progression after first-line systemic therapy: a multicentre, randomised, controlled, phase 2 study;Gomez;Lancet Oncol,2016
5. Local Consolidative Therapy Vs. Maintenance Therapy or Observation for Patients With Oligometastatic Non-Small-Cell Lung Cancer: Long-Term Results of a Multi-Institutional, Phase II, Randomized Study;Gomez;J Clin Oncol,2019
Cited by
2 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献